-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
Smart BioMaterials Consortium (SBMC) Opens Cureon Production Facility in Eindhoven
On October 1, 2025, in front of a full house, Cureon – the new Innovation Center for MedTech and BioTech – officially opened its doors at High Tech Campus Eindhoven. The initiative, driven by High Tech Campus Eindhoven, Smart BioMaterials Consortium (SBMC), Brainport Development, and Brabant Development Agency (BOM), marks a major step forward for healthcare innovation in the region.
read more
Regenerative Medicine for Kidney Patients, Marianne Verhaar
Professor Marianne Verhaar, leading internist specialized in kidney disease, head of the Nephrology Department at UMC Utrecht, led the UMCU’s strategic program Regenerative Medicine & Stem Cells, Regenerative Medicine Utrecht for over 10 years, and one of the leaders of the RegMed XB Kidney Moonshot.
read more
RegMed XB has officially opened its third physical office!
After Maastricht and Utrecht, the new workspace at Bio‑Incubator 4, Leuven, is also dedicated to advancing biomedical life sciences, supporting both start-ups, and innovators.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-